Trial Profile
Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI [acute myocardial infarction] Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Myocardial infarction
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 May 2010 Results published in Heart (British Cardiac Society).
- 14 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology.
- 30 Aug 2008 Endpoint 'pulse wave velocity' has been met.